EW Technical Analysis
As of date:3/2/2021
EW stock price:86.28
EW 50 DMA:86.64
EW 200 DMA:80.18
EW MACD (200-50):-6.46
EW RSI:51.65
Overbought/Oversold RSI Range
RSI Indicator (Relative Strength Index)51.65

Also see:
EW Market Cap History
EW Shares Outstanding History
EW YTD Return

Try ChartSweeps today
Quotes delayed 20 minutes
Get Free SEC filing alerts for EW:
EW SEC Filing Email Alerts ServiceExternal link

INVH Makes Notable Cross Below Critical Moving Average
5 minutes ago

VEEV Makes Notable Cross Below Critical Moving Average
11 minutes ago

Tredegar (TG) Shares Cross Above 200 DMA
27 minutes ago

STERIS Breaks Below 200-Day Moving Average - Notable for STE
30 minutes ago

MNA Crowded With Sellers
32 minutes ago

ZM Crosses Below Key Moving Average Level
4 hours, 28 minutes ago

Materialise (MTLS) Shares Cross Below 200 DMA
4 hours, 36 minutes ago

Aeglea BioTherapeutics (AGLE) Shares Cross Above 200 DMA
4 hours, 36 minutes ago

ANSS Makes Notable Cross Below Critical Moving Average
4 hours, 52 minutes ago

Notable Two Hundred Day Moving Average Cross - ZIXI
4 hours, 54 minutes ago

Essential Utilities Stock Getting Very Oversold
5 hours, 1 minute ago

Ferrari Breaks Below 200-Day Moving Average - Notable for RACE
5 hours, 8 minutes ago

PSXP Crosses Above Key Moving Average Level
5 hours, 13 minutes ago

B&G Foods Breaks Below 200-Day Moving Average - Notable for BGS
5 hours, 13 minutes ago

ZTS Crosses Below Key Moving Average Level
5 hours, 13 minutes ago

More Technical Analysis News

EW Technical AnalysisEW RSI
Edwards Lifesciences is engaged in patient-focused medical for structural heart disease, as well as critical care and surgical monitoring. Co. is a manufacturer of heart valve systems and repair products used to replace or repair a patient's diseased or defective heart valve. Co. is also engaged in hemodynamic and noninvasive brain and tissue oxygenation monitoring systems used to measure a patient's cardiovascular function in the hospital setting. Co.'s products and technologies are categorized into four main areas: Transcatheter Aortic Valve Replacement, Transcatheter Mitral and Tricuspid Therapies, Surgical Structural Heart, and Critical Care.

When researching a stock like Edwards Lifesciences, many investors are the most familiar with Fundamental Analysis — looking at a company's balance sheet, earnings, revenues, and what's happening in that company's underlying business. Investors who use Fundamental Analysis to identify good stocks to buy or sell can also benefit from EW Technical Analysis to help find a good entry or exit point. Technical Analysis is blind to the fundamentals and looks only at the trading data for EW stock — the real life supply and demand for the stock over time — and examines that data in different ways.
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks

10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
Video: Technical Analysis

If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Edwards Lifesciences (EW) is categorized under the Healthcare sector; to help you further research Technical Analysis, below are some other companies in the same sector:

GILD Technical Analysis
HCA Technical Analysis
HOLX Technical Analysis
HSIC Technical Analysis
IDXX Technical Analysis
ILMN Technical Analysis
INCY Technical Analysis
IQV Technical Analysis
ISRG Technical Analysis
JNJ Technical Analysis
More Healthcare companies »


EW Technical Analysis | www.TechnicalAnalysisChannel.com | Copyright © 2019 - 2021, All Rights Reserved

Nothing in TechnicalAnalysisChannel.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.